Pregled bibliografske jedinice broj: 812274
Decrease in catalytic capacity of gamma- secretase can facilitate pathogenesis in sporadic and Familial Alzheimer's disease
Decrease in catalytic capacity of gamma- secretase can facilitate pathogenesis in sporadic and Familial Alzheimer's disease // Molecular and cellular neuroscience, 67 (2015), 55-65 doi:10.1016/j.mcn.2015.06.002. (podatak o recenziji nije dostupan, članak, znanstveni)
CROSBI ID: 812274 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Decrease in catalytic capacity of gamma-
secretase can facilitate pathogenesis in
sporadic and Familial Alzheimer's disease
Autori
Svedružić, Željko ; Popović, Katarina ; Šendula Jengić, Vesna
Izvornik
Molecular and cellular neuroscience (1044-7431) 67
(2015);
55-65
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Early diagnostics ; Familiar Alzheimer's disease mutations ; Pathogenesis
Sažetak
BACKGROUND: Alzheimer's disease can be a result of an age- induced disparity between increase in cellular metabolism of Aβ peptides and decrease in maximal activity of a membrane-embedded protease γ-secretase. RESULTS: We compared activity of WT γ-secretase with the activity of 6 FAD mutants in its presenilin-1 component and 5 FAD mutants in Aβ-part of its APP substrate (Familial Alzheimer's disease). All 11 FAD mutations show linear correlation between the decrease in maximal activity and the clinically observed age-of-onset and age- of-death. Biphasic-inhibitors showed that a higher ratio between physiological Aβ- production and the maximal activity of γ- secretase can be observed in cells that can facilitate pathogenic changes in Aβ-products. For example, Aβ production in cells with WT γ- secretase is at 11% of its maximal activity, with delta-exon-9 mutant at 26%, while with M139V mutant is at 28% of the maximal activity. In the same conditions, G384A mutant is fully saturated and at its maximal activity. Similarly, Aβ production in cells with γ- secretase complex carrying Aph1AL component is 12% of its maximal activity, while in cells with Aph1B complex is 26% of its maximal activity. Similar to the cell-based studies, clinical studies of biphasic dose-response in plasma samples of 54 healthy individuals showed variable ratios between physiological Aβ production and the maximal activity of γ- secretase. CONCLUSIONS: The increase in the ratio between physiological Aβ production and maximal activity of γ- secretase can be an early sign of pathogenic processes in enzyme-based, cell-based, and clinical studies of sporadic and Familiar Alzheimer's disease.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka,
Fakultet zdravstvenih studija u Rijeci
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE